UNCOVER - a Non-interventional Study to Investigate Undiagnosed Severe Asthma
NCT04628260 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 174
Last updated 2023-10-19
Summary
UNCOVER is a non-interventional study to investigate the prevalence of difficult-to-treat and severe Asthma eligible for treatment with biologics in a cohort of patients with suspected, so far undiagnosed severe Asthma which were previously treated by General practitioners and Office-based pulmonologists.
Conditions
Sponsors & Collaborators
-
Universitätsklinik für Innere Medizin II, Pulmologie
collaborator UNKNOWN -
Karl Landsteiner Institute for Clinical and Experimental Pneumology
lead OTHER
Principal Investigators
-
Wolfgang Pohl, Univ. Prof. Dr. · Head of Karl Landsteiner Institut for Clinical and Experimental Pneumology
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-09-21
- Primary Completion
- 2022-09-30
- Completion
- 2023-09-30
Countries
- Austria
Study Locations
More Related Trials
-
Inhaled Steroids and Control of Severe Asthma
NCT01197482 ·Status: TERMINATED
-
Exploring the Lived Experience of Young Adults With Severe Asthma
NCT06681545 ·Status: RECRUITING
-
Assessing Decision Maker Tools for Asthma: the Asthma APGAR
NCT01446315 ·Status: UNKNOWN ·Phase: PHASE4
-
A Dose Finding Study With an Anti-TSLP Antibody (GSK5784283) in Adults Aged 18 to 75 Years of Age With Uncontrolled Asthma
NCT06748053 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System
NCT07136025 ·Status: RECRUITING ·Phase: NA
-
REALL: A Retrospective Observational Study to Compare the Effectiveness and Cost-Effectiveness Between Different Step-3 Asthma Treatment Strategies
NCT00628563 ·Status: COMPLETED
-
Real Life Effectiveness in Patients With Not Optimally Controlled Asthma
NCT00784953 ·Status: COMPLETED
-
Reduce IDentified UNcontrolled Asthma
NCT01449409 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
TNF Alpha in Refractory Asthma
NCT00276029 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of ADC3680B in Subjects With Partly Controlled Atopic Asthma
NCT01448954 ·Status: COMPLETED ·Phase: PHASE2
-
Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy
NCT03629782 ·Status: COMPLETED
-
A Retrospective Chart Review to Investigate Clinical Remission in Patients With Severe Asthma Treated With Biologics in the United Kingdom National Health Service
NCT06261567 ·Status: COMPLETED
-
A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.
NCT01704495 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
NCT06676319 ·Status: RECRUITING ·Phase: PHASE2
-
Comparative Study of the Efficacy of Biologics vs Usual Treatment on OCS Reduction for Severe Asthma Patients Using Health Insurance Claim Database
NCT05136547 ·Status: COMPLETED
-
Impact of Reduction of Dust Mite Allergenic Load on Step Down of Inhaled Corticosteroids in Stable Asthma
NCT02773628 ·Status: TERMINATED ·Phase: NA
-
Evaluation of Dupilumab in Children With Uncontrolled Asthma
NCT02948959 ·Status: COMPLETED ·Phase: PHASE3
-
Mechanisms Underlying Asthma Exacerbations Prevented and Persistent With Immune-Based Therapy
NCT02502890 ·Status: COMPLETED
-
Inhaler Adherence and Inhalation Technique Assessed by a Smart Spacer in Patients with Severe Asthma on Biologics
NCT06360393 ·Status: RECRUITING
-
Use of Aptar Digital Health's Respiratory Disease Management Platform for Asthma
NCT06364527 ·Status: COMPLETED ·Phase: NA
-
Pragmatic Clinical Trial to Assess the Effectiveness of Pharmaceutical Intervention in Patients With Uncontrolled Asthma
NCT06227793 ·Status: RECRUITING ·Phase: NA
-
Launching an Asthma Initiative Designed to Improve Asthma Management and Outcomes
NCT02140671 ·Status: UNKNOWN
-
Study to Assess the Efficacy and Safety of Atuliflapon in Moderate-to-Severe Uncontrolled Asthma
NCT05251259 ·Status: COMPLETED ·Phase: PHASE2
-
A Pragmatic Trial of Corticosteroid Optimisation in Severe Asthma
NCT02717689 ·Status: COMPLETED ·Phase: NA
-
Longitudinal Phenotyping and Endotyping Study in Adult Patients With Mild, Moderate, or Severe Asthma
NCT07189806 ·Status: RECRUITING